Practical considerations to implement the shorter regimen to MDR-TB patients in China

被引：3
作者：
Liu, Q. [1 ]
Sun, F. [1 ]
Li, Y. [1 ]
Bao, J. [2 ]
Zhang, Y. [1 ,3 ]
Zhang, W. [1 ]
机构：
[1] Fudan Univ, Huashan Hosp, Dept Infect Dis, 12 WulumuqiZhong Rd, Shanghai 200040, Peoples R China
[2] NIAID, TB Clin Res Branch, Div AIDS, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2018年 / 24卷 / 10期
关键词：
MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; BENEFIT; EUROPE;
D O I：
10.1016/j.cmi.2018.04.026
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1035 / 1036
页数：2
相关论文
共 50 条
[31]   Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java']Java Indonesia [J].
Soeroto, Arto Yuwono ;
Nurhayati, Raden Desy ;
Purwiga, Aga ;
Lestari, Bony Wiem ;
Pratiwi, Chica ;
Santoso, Prayudi ;
Kulsum, Iceu Dimas ;
Suryadinata, Hendarsyah ;
Ferdian, Ferdy .
PLOS ONE, 2022, 17 (01)
[32]   Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China [J].
Liu, Y. ;
Sun, Y. ;
Zhang, X. ;
Zhang, Z. ;
Xing, Q. ;
Ren, W. ;
Yao, C. ;
Yu, J. ;
Ding, B. ;
Wang, S. ;
Li, C. .
EPIDEMIOLOGY AND INFECTION, 2021, 149
[33]   Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen [J].
Singh, Sanjay ;
Gumbo, Tawanda ;
Alffenaar, Jan-Willem ;
Boorgula, Gunavanthi D. ;
Shankar, Prem ;
Thomas, Tania A. ;
Dheda, Keertan ;
Malinga, Lesibana ;
Raj, Prithvi ;
Aryal, Santosh ;
Srivastava, Shashikant .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (06)
[34]   Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB: HIV study [J].
Efsen, A. M. W. ;
Schultze, A. ;
Miller, R. F. ;
Panteleev, A. ;
Skrahin, A. ;
Podlekareva, D. N. ;
Miro, J. M. ;
Girardi, E. ;
Furrer, H. ;
Losso, M. H. ;
Toibaro, J. ;
Cayla, J. A. ;
Mocroft, A. ;
Lundgren, J. D. ;
Post, F. A. ;
Kirk, O. .
JOURNAL OF INFECTION, 2018, 76 (01) :44-54
[35]   Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia [J].
Putri, F. A. ;
Burhan, E. ;
Nawas, A. ;
Soepandi, P. Z. ;
Sutoyo, D. K. ;
Agustin, H. ;
Isbaniah, F. ;
Dowdy, D. W. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (05) :564-570
[36]   Patients' perceived quality of care and their satisfaction with care given for MDR-TB at referral hospitals in Ethiopia [J].
Wakjira, Mengistu ;
Sandy, Peter ;
Mavhandu-Mudzusi, A. H. .
PLOS ONE, 2023, 18 (02)
[37]   Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study [J].
Huang, Zikun ;
Qin, Cheng ;
Du, Jinghui ;
Luo, Qing ;
Wang, Yaoxing ;
Zhang, Wang ;
Zhang, Xi ;
Xiong, Guoliang ;
Chen, Jie ;
Xu, Xiaomeng ;
Li, Weiting ;
Li, Junming .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (02) :456-462
[38]   Fluroquinolone drug resistance among MDR-TB patients increases the risk of unfavourable interim microbiological treatment outcome: An observational study [J].
Singh, Nishtha ;
Singh, Pravin Kumar ;
Singh, Urmila ;
Garg, Rajiv ;
Jain, Amita .
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 24 :40-44
[39]   Are We Doing Enough to Stem the Tide of Acquired MDR-TB in Countries with High TB Burden? Results of a Mixed Method Study in Chongqing, China [J].
Li, Ying ;
Ehiri, John ;
Oren, Eyal ;
Hu, Daiyu ;
Luo, Xingneng ;
Liu, Ying ;
Li, Daikun ;
Wang, Qingya .
PLOS ONE, 2014, 9 (02)
[40]   Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India [J].
Shewade, H. D. ;
Shringarpure, K. S. ;
Parmar, M. ;
Patel, N. ;
Kuriya, S. ;
Shihora, S. ;
Ninama, N. ;
Gosai, N. ;
Khokhariya, R. ;
Popat, C. ;
Thanki, H. ;
Modi, B. ;
Dave, P. ;
Baxi, R. K. ;
Kumar, A. M. V. .
PUBLIC HEALTH ACTION, 2018, 8 (02) :59-65
12345